The deadline to bid for Byju's assets has been extended to January 15. This gives potential buyers more time for due ...
Earlier, on November 27, 2025, the Board of Directors of AESL had decided to keep the allotment of shares to TLPL in abeyance ...
The petition filed by Aakash Educational Services questioned the legality of the funds raised by Think & Learn to subscribe ...
Alphyn Biologics, Inc., a clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics®, today announced the close of its $25 million, twice-oversubscribed Series B financing ...
The Delaware Court has reversed the $1 billion Judgement against Byju Raveendran (Director, Byjus Investments Pvt. Ltd.), in view of fresh submissions made by Byju Raveendran through a motion to ...
A US bankruptcy court has reversed a $1 billion damages ruling against Byju Raveendran, founder of ed-tech firm Byju’s, offering temporary relief to the embattled entrepreneur as one of the most ...
In a longish post on social media platform X, Unacademy co-founder Gaurav Munaj confirmed that his firm is actively in talks ...
The founders of Think and Learn Pvt Ltd, the parent company of Byju's, in a statement said that the US court agreed that damages had not been determined and ordered a new phase to commence in January ...
Court agreed that damages had not been determined and ordered a new phase to commence in early January 2026 to determine any ...
The resolution professional of debt-laden ed-tech Think and Learn Pvt Ltd (Byju's) has moved an application before the ...
In 2025, India's corporate landscape faced significant turmoil despite a projected 7% GDP growth., Companies, Times Now ...
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that clinical data from its allogeneic BCMA-targeted CAR T-cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results